坏死性外耳道炎继发颈椎骨髓炎1例并文献复习

doi:10.6040/j.issn.1673-3770.0.2022.174

摘要/Abstract

摘要： 目的探讨坏死性外耳道炎继发颈椎骨髓炎的诊疗方法及临床特点。方法回顾性分析1例糖尿病老年患者坏死性外耳道炎合并C2-C6颈椎椎体骨髓炎的病历资料并检索文献,总结其临床表现、诊断、治疗方法及预后。结果检索获得2005~2022年国内外发表的5篇文献, 加上本例患者共纳入4个病例,其中男3例、女1例,54~72岁,除1例有头颈部放疗史外其余3例均合并糖尿病,病变范围均广泛,累及2~5个颈椎椎体,病原体为不同细菌,经过系统治疗后,3例(75%)死亡,与细菌耐药、患者依从性差及全身健康状况差可能有关。结论坏死性外耳道炎病变可从颅底骨髓炎进一步扩展至颈椎骨髓炎危及生命,需要积极治疗。

关键词: 坏死性外耳道炎, 骨髓炎, 糖尿病, 颈椎

Abstract: Objective To outline and analyze the clinical features and treatment option of cervical osteomyelitis secondary to necrotizing otitis externa. Methods We performed a retrospective review, along with literature review, of a case of C2-C6 osteomyelitis secondary to a necrotizing otitis externa in a diabetic patient, in order to outline its clinical manifestation, diagnosis, treatment option and prognosis. Results A total of five relevant studies published in Chinese and English from 2005 to 2022 were reviewed, and four cases(including the case presented in this study)were analyzed. The four cases involved three men and one woman(age range: 54-72 years). Only one patient had a history of head and neck radiotherapy, the remaining three were known diabetic patients. The lesions were extensive, involving two to five vertebral bodies. The causative pathogens isolated were all bacteria; however, the strains varied among the cases. After a systematic treatment, three patients(75%)succumbed to the disease as a result of bacterial resistance, poor compliance to medications, and severe comorbidity. Conclusion The lesions of necrotizing otitis externa can extend from the skull base to the cervical vertebrae, causing cervical osteomyelitis: a life-threatening condition that requires an aggressive treatment.

Key words: Necrotizing otitis externa, Osteomyelitis, Diabetes, Cervical vertebrae

中图分类号:

R764.1+1

田俊, 刘良发, 白佳麒. 坏死性外耳道炎继发颈椎骨髓炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 1-5.

TIAN Jun, LIU Liangfa, BAI Jiaqi. Cervical vertebral osteomyelitis secondary to necrotizing otitis externa:a case report and review of literature[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 1-5.

参考文献

[1] 江远明, 马志跃, 肖红俊. 坏死性外耳道炎[J]. 临床耳鼻咽喉头颈外科杂志, 2007, 21(4): 185-187. doi:10.3969/j.issn.1001-1781.2007.04.020.
[2] Treviño González JL, Reyes Suárez LL, Hernández de León JE. Malignant otitis externa: an updated review[J]. Am J Otolaryngol, 2021, 42(2): 102894. doi:10.1016/j.amjoto.2020.102894.
[3] Marina S, Goutham MK, Rajeshwary A, et al. A retrospective review of 14 cases of malignant otitis externa[J]. J Otol, 2019, 14(2): 63-66. doi:10.1016/j.joto.2019.01.003.
[4] Chandler JR. Malignant external otitis[J]. Laryngoscope, 1968, 78(8): 1257-1294. doi:10.1288/00005537-196808000-00002.
[5] Glikson E, Sagiv D, Wolf M, et al. Necrotizing otitis externa: diagnosis, treatment, and outcome in a case series[J]. Diagn Microbiol Infect Dis, 2017, 87(1): 74-78. doi:10.1016/j.diagmicrobio.2016.10.017.
[6] 屠冠军, 金明熙, 朱悦, 等. 脊柱化脓性骨髓炎的诊断及治疗[J]. 中华骨科杂志, 2004, 24(6): 355-358. doi:10.3760/j.issn: 0253-2352.2004.06.009. TU Guanjun, JIN Mingxi, ZHU Yue, et al. Diagnosis and treatment of pyogenic spinal osteomyelitis[J]. Chinese Journal of Orthopaedics, 2004, 24(6): 355-358. doi:10.3760/j.issn: 0253-2352.2004.06.009.
[7] Low G, Leong A, George R, et al. C1/C2 osteomyelitis secondary to malignant otitis externa complicated by atlantoaxial subluxation-a case report and review of the literature[J]. AME Case Rep, 2020, 4: 19. doi:10.21037/acr.2020.03.04.
[8] 黄冠又, 曹楚南, 甘鸿川. 颅底骨髓炎的研究进展[J]. 国际神经病学神经外科学杂志, 2015, 42(1): 66-69. doi:10.16636/j.cnki.jinn.2015.01.012.
[9] Prasad KC, Prasad SC, Mouli N, et al. Osteomyelitis in the head and neck[J]. Acta Otolaryngol, 2007, 127(2): 194-205. doi:10.1080/00016480600818054.
[10] Singh A, Al Khabori M, Hyder MJ. Skull base osteomyelitis: diagnostic and therapeutic challenges in atypical presentation[J]. Otolaryngol Head Neck Surg, 2005, 133(1): 121-125. doi:10.1016/j.otohns.2005.03.024.
[11] Bruschini L, Berrettini S, Christina C, et al. Extensive skull base osteomyelitis secondary to malignant otitis externa[J]. J Int Adv Otol, 2019, 15(3): 463-465. doi:10.5152/iao.2019.5406.
[12] Arsovic N, Radivojevic N, Jesic S, et al. Malignant otitis externa: causes for various treatment responses[J]. J Int Adv Otol, 2020, 16(1): 98-103. doi:10.5152/iao.2020.7709.
[13] Meltzer PE, Kelemen G. Pyocyaneous osteomyelitis of the temporal bone, mandible and zygoma.[J]. Laryngoscope,1959,169:1300-1316.doi:10.1288/00005537-195910000-00006.
[14] Nadol JB Jr. Histopathology of Pseudomonas osteomyelitis of the temporal bone starting as malignant external otitis[J]. Am J Otolaryngol, 1980, 1(5): 359-371. doi:10.1016/s0196-0709(80)80016-0.
[15] Peled C, El-Seid S, Bahat-Dinur A, et al. Necrotizing otitis externa-analysis of 83 cases: clinical findings and course of disease[J]. Otol Neurotol, 2019, 40(1): 56-62. doi:10.1097/MAO.0000000000001986.
[16] Berbari EF, Kanj SS, Kowalski TJ, et al. 2015 infectious diseases society of America(IDSA)clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults[J]. Clin Infect Dis, 2015, 61(6): e26-e46. doi:10.1093/cid/civ482.
[17] Bernard L, Dinh A, Ghout I, et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial[J]. Lancet, 2015, 385(9971): 875-882. doi:10.1016/S0140-6736(14)61233-2.
[18] Sturm JJ, Stern Shavit S, Lalwani AK. What is the best test for diagnosis and monitoring treatment response in malignant otitis externa? [J]. Laryngoscope, 2020, 130(11): 2516-2517. doi:10.1002/lary.28609.
[19] Sokoowski J, Lachowska M, Karchier E, et al. Skull base osteomyelitis: factors implicating clinical outcome[J]. Acta Neurol Belg, 2019, 119(3): 431-437. doi:10.1007/s13760-019-01110-w.
[20] Ju KL, Kim SD, Melikian R, et al. Predicting patients with concurrent noncontiguous spinal epidural abscess lesions[J]. Spine J, 2015, 15(1): 95-101. doi:10.1016/j.spinee.2014.06.008.

相关文章 15

[1]	赵娟,焦万珍,赵博军. UWFSS-OCTA检测糖尿病视网膜病变微循环的变化[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 80-86.
[2]	朱明琼,李征,刘茹,田涛,彭婧利,吕倩怡,谭华霞. 基于OCT/OCTA的AI筛查系统在抗VEGF治疗糖尿病性黄斑水肿患者效果评价中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 68-73.
[3]	孙庆祝,沈健,陈星,吴雁冰,曾论. 代谢指标在预测糖尿病性黄斑水肿患者雷珠单抗疗效中的作用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 74-81.
[4]	李赞,卢奇,申卫东,侯昭晖,吴南. 坏死性外耳道炎临床诊治18例[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 17-22.
[5]	高琳,何金梅,杨明祎. 糖尿病视网膜病变患者血清Sestrin2和NADPH氧化酶2水平与眼底病变的相关性[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 113-117.
[6]	辛梦,纪芳,代春华,张靖,刘澍. 医用透明质酸钠与平衡盐溶液在微创玻璃体手术中对眼表保护的影响[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 58-65.
[7]	沈嘉琪,李潇飒,毕燕龙,张敬法. 人工智能在DME筛查、诊断和预后中的应用[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 153-159.
[8]	鲍莹,刘志高,姜鹏飞,崔文轩,郑晓霞,杨梦瑶,司明威,王玉,王红. 康柏西普治疗糖尿病合并CRVO-ME高反射点的临床观察[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 55-60.
[9]	常威威,焦万珍,崔艳艳,赵杰,刘兆强,赵博军. 糖尿病性黄斑缺血的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 130-136.
[10]	周静琳,李金香,曾琦. 577 nm阈值下微脉冲激光联合抗VEGF药物治疗难治性糖尿病性黄斑水肿的疗效观察[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 18-25.
[11]	何静,雷春燕,张美霞. 糖化血红蛋白变异指数与糖尿病视网膜病变严重程度的相关性研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 34-40.
[12]	李淑婷,赵慧,司明威,崔文轩,杨梦瑶,王红. 无植物性外伤史患者感染真菌性眼内炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 103-108.
[13]	伦英俊,陈晨,高宏程,范清琳,邰仁清. TLR4/NF-κB通道在糖尿病视网膜病变中的作用[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 163-168.
[14]	卢淦,邓玉琴,陶泽璋. 过敏性疾病与糖尿病的相关性及潜在关联机制[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 215-222.
[15]	唐慧新,李景景,邹红. 阈值下微脉冲激光光凝作用机制及临床应用[J]. 山东大学耳鼻喉眼学报, 2023, 37(3): 143-148.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed